Document is current
Any future updates will be listed below
-
Authors
Chaussin, Benjamin
Sanchez, Lucie
Levesque, Sophie
Revy, Alban
Tempier, Marion
Montemagno, Christopher
Durivault, Jérôme
Schmitt, Sébastien
Boutault, Erwan
Besse, Sophie
Chautard, Emmanuel
Auriol, Manon
Voissiere, Aurélien
Kossaï, Myriam
Miot-Noirault, Elisabeth
Penault-Llorca, Frédérique
Merlin, Charles
Cachin, Florent
Jouberton, Elodie
-
Funding
Funding for this research was provided by:
Ligue régionale contre le cancer comité de l’Allier et du Cantal
- License Information
-
More Information
Article History
Received: 20 October 2025
Accepted: 14 January 2026
First Online: 16 February 2026
Declarations
:
: The authors declare no competing interests.
: The study was conducted in accordance with ARRIVE guidelines (https://arriveguidelines.org) and approved protocols outlined by the Auvergne Local Ethics Committee C2E2A and the French Ministry of Education and Research (approval numbers 49893 and 23955). No human studies were conducted. The maximum tumor size permitted by the local ethics committee, (1500 mm3), was never reached by any mouse in this study.
